3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Astrocytoma
8
Glioblastoma
5
Neuroectodermal Tumors, Primitive
3
Recurrence
2
Oligodendroglioma
2
Neurocytoma
2
Lymphoma, Non-Hodgkin
2
Glioma
2
Brain Neoplasms
2
Rhabdoid Tumor
1
Pancreatic Neoplasms
1
Neoplasms, Unknown Primary
1
Multiple Myeloma
1
Mesothelioma, Malignant
1
Meningioma
1
Melanoma
1
Lung Neoplasms
1
Gliosarcoma
1
Ganglioglioma
1
Esophageal Neoplasms
1
Ependymoma
1
Craniopharyngioma
1
Carcinoma, Non-Small-Cell Lung
1
Adrenocortical Carcinoma
1
Adenocarcinoma Of Esophagus
1
Interventions
Bevacizumab
3
ribociclib
2
Temozolomide
2
Radiotherapy
2
Radiation
2
Panobinostat
2
pembrolizumab
1
dipinacoline glutamate
1
dinutuximab
1
cemiplimab
1
adavosertib
1
abemaciclib
1
Vorinostat
1
Valproic Acid
1
Re-Irradiation
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Nivolumab
1
Maintenance
1
Irinotecan
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Everolimus
1
Erlotinib Hydrochloride
1
Congresses as Topic
1
Chemotherapy, Adjuvant
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Diffuse Intrinsic Pontine Glioma
×
antineoplaston AS 2-1
×
Clear all
No trials found.